Scholar Rock Holding Corp Asset Resilience Ratio
Scholar Rock Holding Corp asset resilience ratio. Scholar Rock Holding Corp (SRRK) has an Asset Resilience Ratio of 20.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Scholar Rock Holding Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Scholar Rock Holding Corp (2016–2024)
Asset resilience ratio of Scholar Rock Holding Corp from 2016 to 2024. This chart shows how Scholar Rock Holding Corp's Asset Resilience Ratio has changed over time. Read SRRK total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Scholar Rock Holding Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Scholar Rock Holding Corp.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $82.86 Million | 20.13% |
| Total Liquid Assets | $82.86 Million | 20.13% |
Asset Resilience Insights
- Good Liquidity Position: Scholar Rock Holding Corp maintains a healthy 20.13% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Scholar Rock Holding Corp Industry Peers by Asset Resilience Ratio
Compare Scholar Rock Holding Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
Biotechnology | 33.37% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Bavarian Nordic
CO:BAVA |
Biotechnology | 10.83% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Scholar Rock Holding Corp Asset Resilience Ratio by Year (2016–2024)
Scholar Rock Holding Corp asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Scholar Rock Holding Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 54.62% | $259.40 Million | $474.92 Million | -2.64pp |
| 2023-12-31 | 57.25% | $178.08 Million | $311.04 Million | -1.96pp |
| 2022-12-31 | 59.21% | $212.09 Million | $358.17 Million | +46.02pp |
| 2021-12-31 | 13.19% | $40.16 Million | $304.44 Million | -33.34pp |
| 2020-12-31 | 46.53% | $180.67 Million | $388.31 Million | -15.16pp |
| 2019-12-31 | 61.69% | $121.14 Million | $196.38 Million | +28.28pp |
| 2018-12-31 | 33.41% | $60.58 Million | $181.34 Million | +30.98pp |
| 2017-12-31 | 2.43% | $1.50 Million | $61.64 Million | -52.48pp |
| 2016-12-31 | 54.91% | $18.00 Million | $32.78 Million | -- |
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more